Skip to main content

Initial Opioid Prescribing for Long Duration (IOP-LD)

CBE ID
3558
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Fall 2025
1.3 Measure Description

The percentage of individuals 18 years of age and older with one or more initial opioid prescriptions for >7 cumulative days’ supply.

        • 1.5 Measure Type
          1.7 Electronic Clinical Quality Measure (eCQM)
          1.8 Level Of Analysis
          1.20 Testing Data Sources
        • 1.14 Numerator

          The number of individuals from the denominator with >7 cumulative days’ supply for all opioid prescription claims within any opioid initiation period.

          The opioid initiation period is defined as the date of service of the initial opioid prescription plus two days, i.e., the 3-day time period when the numerator is assessed.

        • 1.15 Denominator

          The denominator includes individuals 18 years of age or older with one or more prescription claims for an opioid and a negative medication history for any opioid medication during the 90-day lookback period.

        • Exclusions

          Individuals with cancer, sickle cell disease, or in hospice at any point during the measurement year or the 90 days prior to the first day of the measurement year are excluded from the denominator.

        • OLD 1.12 MAT output not attached
          Attached
          1.13a Data dictionary not attached
          No
        • Most Recent Endorsement Activity
          Endorsed Patient Safety Spring Cycle 2020
          Initial Endorsement
          Last Updated
              • Risk adjustment approach
                Off
                Risk adjustment approach
                Off
                Conceptual model for risk adjustment
                Off
                Conceptual model for risk adjustment
                Off